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Transoral videolaryngoscopic surgery (TOVS) for laryngopharyngeal cancer 
developed by Shiotani et al., uses the laparoscopic surgical system and distend-
ing laryngoscope. This method enables precise procedures and en bloc resection 
under a good view with videoendoscope in the structurally complex laryngo-
pharynx. The major indications are Tis-2, and selected T3 lesions of hypopharyn-
geal, oropharyngeal, and supraglottic laryngeal cancer. TOVS is also considered 
for resectable rT1 and rT2 radiation failure cases and selected T3–4 advanced 
cases following neoadjuvant chemotherapy. Patients with resectable lymph node 
metastases are treated by neck dissection. Major contraindications are crico-
arytenoid joint fixation, circumferential invasion of more than half, bilateral 
arytenoid invasion, and invasion to the thyroid cartilage, cricoid cartilage, hyoid 
bone, deep pharyngeal constrictor muscle. Oncological outcomes are good in 
long-term survival and larynx preservation rates with sparing radiation in half 
of the patients. However, advanced T stage and N3 cases showed a worse prog-
nosis. Regarding functional outcome, swallowing function can maintain in most 
patients. Postoperative voice impairment can occur after wound healing. TOVS 
has some advantages particularly for hypopharyngeal cancer, in maneuver with 
smaller diameter instruments and tactile sense, and in less invasiveness without a 
tracheostomy, compared to other transoral surgeries.
Keywords: Transoral videolaryngoscopic surgery (TOVS), transoral surgery, 
hypopharyngeal cancer, swallowing function, voice impairment, sentinel node 
navigation surgery, conversion surgery, neoadjuvant chemotherapy
1. Introduction
Transoral videolaryngoscopic surgery (TOVS) for laryngopharyngeal cancer 
was developed by Shiotani and his colleagues in Japan since 2004 and the first 
report was published in 2010 [1–4]. This novel endoscopic transoral surgical system 
uses the laparoscopic surgical system and distending laryngoscope which enables en 
bloc resection under a good view with videoendoscope. Recently, surgical instru-
ments used in TOVS have been modified to some extent. Good long-term survival, 
larynx preservation, and functional outcomes were reported [5]. In this chapter, 
the tips and the pearls of TOVS including detail of the surgical procedures, manage-
ments, and outcomes are described.
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2. The feature of TOVS
The break out of transoral surgery for laryngopharyngeal cancer was started from 
transoral laser microsurgery (TLM), developed by Steiner et al. [6]. TLM is suitable 
for glottic lesions which are required fine and precise maneuver in a limited nar-
row space. Although TLM yields good oncological outcomes, the microscopic view 
through a rigid laryngoscope is linear and is not wide enough to observe the entire 
laryngopharynx. Particularly when observing the postcricoid area and inner surface 
of the epiglottis, it is often hidden by the blade of the laryngoscope. Multiple reposi-
tioning of the laryngoscope is also needed when the lesion is relatively large. In addi-
tion, pathological workup is difficult when piece-by-piece resection is performed.
To overcome these drawbacks, TOVS was developed. The endoscopic view under 
a flexible videoscope is wider than that under a microscope, and a wide working 
space can be achieved by using the FKWO retractor. This method enables detailed 
observation, precise procedures, and en bloc resection in the structurally complex 
laryngopharynx.
Although transoral robotic surgery (TORS) is actively performed for hypopha-
ryngeal cancer in South Korea, tracheostomy is required because the intubation 
tube interferes with the arms of the robot [7]. In TOVS, a videoscope and forceps 
with a smaller diameter than the arms of the robot are used; hence, surgical proce-
dure without tracheostomy is possible even in the narrow and distal spaces such as 
the hypopharynx. In addition, the surgeon has tactile sense through instruments. 
Therefore, TOVS has some advantages in maneuver and is less invasive compared to 
TLM and TORS, particularly for hypopharyngeal cancer.
3. Indications
The major indications for TOVS are Tis, T1, and T2 lesions of hypopharyngeal, 
oropharyngeal, and supraglottic laryngeal cancer. TOVS is also indicated for 
selected T3 lesions without deep invasion. Furthermore, TOVS is considered for 
small radiation failure cases (rT1 and rT2) if the lesions are resected with enough 
margins [8]. TOVS is also considered in advanced T3 or T4 cases after the tumor 
shrinks to a limited area following neoadjuvant chemotherapy (NAC). However, it 
is not a standard indication due to issues in the resection area, possibly leading to 
oncologically inadequate resection, as described in Section 11.3 (Table 1).
Anatomical contraindications for TOVS are cricoarytenoid joint fixation due to 
cancer invasion, circumferential invasion of more than half of the esophageal inlet, 
bilateral arytenoid invasion, and invasion to the thyroid cartilage, cricoid carti-
lage, hyoid bone, deep pharyngeal constrictor muscle, hard palate, and pterygoid 
hamulus. Oncologically sufficient resection is technically difficult, and functional 
preservation may not be excellent because of dysphagia and respiratory disorders 
due to postoperative stenosis and vocal cord movement restriction.
Patients with resectable lymph node metastases are treated by neck dissection 
(ND) along with TOVS on the same day or 1–2 weeks later. TOVS is generally per-
formed in N1–N2 cases; however, although they are technically resectable, TOVS is not 
generally indicated in N3 cases due to poor prognosis [5]. Considering that postopera-
tive chemoradiotherapy is needed in most N3 cases, transoral surgery has little signifi-
cance due to increased invasiveness without improvement in oncological outcomes.
Although the extent of lesions is the basis of decision making for surgical indica-
tions, the final decision is made by considering the systemic condition. Preoperative 
swallowing function should be evaluated in cases predisposed to dysphagia, and 
surgical indication should be conservatively decided. Age; performance status; 
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medical history including radiation history; comorbidities such as respiratory 
diseases, cardiovascular diseases, and diabetes; and family environments should 
also be considered.
4. Devices
The FKWO retractor (Figure 1a, Olympus medical systems, Tokyo, Japan) with 
various blades is used to expose the laryngo-hypopharynx and widen the operative 
field of view in most cases. Weerda distending video laryngoscope (8588BV; Karl 
Storz, Tuttlingen, Germany) is also useful.
Endoeye flex (LTE-S190–5, Olympus Medical Systems, Tokyo, Japan; Figure 1b), 
an HD videoendoscope with a thin 5-mm diameter and an articulating tip that can 
bend in all directions up to 100°, is used to observe the surgical field in most cases. 
This endoscope is suitable to observe the structurally complex laryngopharynx with 
minimal device conflict during transoral surgery. In addition, it has the function 
of image-enhanced endoscopy (narrow-band imaging: NBI), which is useful for 
evaluating the extent of mucosal lesions. A rigid laryngeal endoscope (8575AV; Karl 
Storz), connected to a high-definition camera set (22220150–3; Karl Storz), also 
provides a wide and clear view.
For forceps, scissors, electrocautery electrodes, suction coagulators, and 
clip applicators, reusable straight devices are used. Incision and separation are 
performed using laparoscopic surgical instruments measuring 3 mm in diameter 
connected to an ordinary electrocautery unit, including separating (30721MD; Karl 
Storz) or scissor-type (30721 MW; Karl Storz) tip forceps and hook-type (26870UF; 
Karl Storz) or needle-type (26167NX; Karl Storz) scalpels. For hemostasis, a suc-
tion coagulator (8606E; Karl Storz) or hemostatic clips (8665 L and 8665R; Karl 
Storz) are used (Figure 1c).
New malleable or curved devices, including LaryngoFIT forceps and scissors 
(8791GHZ, 8793AZ, 8791AZ, and 8794AZ, Karl Storz, Tuttlingen, Germany), a 
malleable needle electrocautery electrode (KD600, Olympus medical systems, 
Tokyo, Japan), a fiber guide CO2 laser (AcuPulse DUO, Lumenis, Yokneam Illit, 
Israel), and a malleable suction coagulator (7030010, Amco, Tokyo, Japan), have 
been recently shown to be very helpful (Figure 1d). Most of these devices have a 
Primary site Hypopharynx, oropharynx, supraglottic cancer
Tis-T2, selected T3 cases
Resectable rT1–2 cases
Seleted advanced T cases following NAC
Contraindications
Cricoarytenoid joint fixation
Circumferential invasion of more than half
Bilateral arytenoid invasion






Neck dissection along with TOVS
Other factors Preoperative swallowing function
Radiation history, Comorbidity (cardiorespiratory diseases, diabetes etc.)
Age, Performance status, Family environments
Table 1. 
Indications for TOVS.
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thin shaft of approximately 3 mm in diameter, except for the malleable suction 
coagulator, which has a thin shaft measuring 5 mm in diameter. These devices are 
effective for approaching from any direction in the view of the endoscope, allowing 
the surgeon to make parallel or perpendicular cuts along the line of sight [5].
5. Surgical procedures
5.1 Setting
TOVS is performed under general anesthesia by orotracheal intubation using a 
small diameter (6–7 mm) reinforced endotracheal tube. When the resection area 
includes the epiglottis and tongue base, nasotracheal intubation is recommended.
To expose the surgical fields, a FKWO retractor with various blades, includ-
ing large blade, laryngeal blade, and tongue base blades, is the most useful 
for laryngopharyngeal lesions. Attaching pre-made mouthpieces to prevent 
tooth injury is also recommended. Although surgical field exposure is the most 
principal and important step to complete transoral surgery successfully, it is one 
of the most difficult steps that requires extensive experience and many learn-
ing curves.
Basic techniques for obtaining good surgical field exposure are as follows. For 
piriform sinus lesions, the laryngeal blade or tongue base blade is inserted into the 
glottis, vallecula of the epiglottis, or anterior end of the piriform sinus lateral of the 
pharyngoepiglottic fold and the aryepiglottic fold (Figure 2a, b). For posterior wall 
Figure 1. 
Devices for TOVS. a. FKWO retractor, b. Endoeye flex, c. straight devices - forceps, scissors, electrocautery 
electrodes, suction coagulators, and clip applicators, d. malleable and curved devices - curved forceps, malleable 
forceps and scissors, malleable needle electrocautery electrode, malleable suction coagulator, curved suction, 
malleable and curved handpieces of fiber guide CO2 laser.
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lesions, the laryngeal blade is inserted into the glottis or postcricoid area (Figure 2c). 
In some of these cases, it is effective and helpful to obtain good surgical fields that 
the blade is inserted behind the endotracheal tube, and the tube is pushed forward 
(Figure 2b, c). For postcricoid and esophageal inlet lesions, the laryngeal blade is 
inserted into the glottis or postcricoid area behind the endotracheal tube, and the 
tube is pushed forward (Figure 2d, e). For epiglottic and tongue-based lesions, the 
tongue base blade is inserted into the tongue base (Figure 2f). Poor ventilation by 
kinking of the tracheal tube can occur due to compression by the blade, and a careful 
procedure is needed.
These instruments can expose most lesions; however, some patients have 
poor laryngopharyngeal exposure. For patents who have poor laryngopharyngeal 
exposure by conventional blades, novel prototypes of curved blades are currently 
under development (Figure 3). These new blades are effective to expose the distal 
hypopharynx to the esophageal inlet [5].
5.2 Evaluation
TOVS is performed by two head and neck surgeons. The operator manipulates 
instruments bimanually, and the assistant holds the videoscope to maintain an 
appropriate view of the surgical fields (Figure 4a). Occasionally, the assistant holds 
another pair of forceps or a suction device to support operator (Figure 4).
To evaluate the extent of the lesions and mark the resection area of the 
laryngopharynx, Endoeye flex with the function of image-enhanced endoscopy 
(NBI) is an ideal tool for this surgery. After meticulous washing of the laryngo-
pharynx to remove blood and saliva with physiological saline, the lesion extent 
is evaluated by endoscopic vision with normal light and NBI (Figure 4b, c). 
Subsequently, iodine staining is performed to show the mucosal extent of the 
lesions. After 1% iodine solution is sprayed around the lesions and rinsed with 
physiological saline, superficial lesions can be clearly demarcated as iodine-
unstained areas (Figure 4d). This procedure is particularly effective in identify-
ing the boundary of lesions in hypopharyngeal cancer and oropharyngeal cancer, 
except that of tongue base lesions.
Palpation using forceps is also an important procedure to evaluate tumor size 
and deep infiltration and determine whether the lesions can be resected. In the case 
of lesion immovability and/or finding anatomical contraindications during the 
evaluation process, discontinuation of TOVS should be considered.
Figure 2. 
Technique of surgical field exposure. a. Right piriform sinus lesion, b. right piriform sinus lesion, c. posterior 
wall lesion, d. Postcricoid lesion, e. esophageal inlet lesion, f. Epiglottic lesion.
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Thereafter, the incision line of the mucosa around the lesions is marked with 
a safety margin of 5–10 mm using needle-type electrocautery (Figure 4e). Due to 
cases of multiple sporadic mucosal lesions, evaluation of the entire laryngopharynx 
is recommended.
5.3 Resection
A soft suction tube is placed transnasally to prevent blurry vision by smoke and 
blood. After circumferential mucosal incision, the operator manipulates the grasp-
ing forceps to grasp and retract the edge of the lesion. Appropriate counter traction 
is applied to determine the appropriate incision layer and enables resection of 
appropriate tissue by electrocautery. In many cases, resection from the periphery to 
the inside enables en block resection (Figure 4f–j). It is important to confirm deep 
infiltration by palpation during the procedure. Representative cases are presented in 
Section 9.
Although hemostasis can be performed with a suction coagulator in most cases, 
multiple vessel clips should be used when thick blood vessels can be confirmed 
(Figure 4k). Bleeding from the posterior wall, the branch of the superior laryngeal 
artery running from the upper outside of the thyroid cartilage, or the branch of the 
lingual artery, is occasionally difficult to control.
Frozen section pathological analysis with the stumps of surgical margins in 
at least four horizontal directions and a deep margin is performed. In addition, 
the extracted specimen is stained with iodine to confirm the sufficiency of safety 
margin. Additional resection is performed based on these results when necessary.
5.4 End of surgery
In some cases, fibrin glue is sprayed to the wound to prevent bleeding (Figure 4l). 
However, it is not necessary due to the possibility of it becoming a foreign body in the 
airways. A nasogastric tube is inserted in cases with a high possibility of postopera-
tive dysphagia (Figure 4).
Figure 3. 
Novel blades for FKWO retractor. A: Prototype of curved blades, b: Representative case (Postcricoid lesion), 
conventional blade (left), curved blade (right).
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Local steroid injection (triamcinolone acetonide) is also performed to reduce 
the degree of postoperative scar contracture in selected non-irradiated cases. In 
deeply invasive tumors and previously irradiated patients, this procedure may cause 
wound healing complications; hence, local steroid injection should be considered 
in only new cases with extensive excision of the pyriform sinus, postcricoid, and/or 
esophageal inlet lesions [9].
TOVS can be completed without tracheostomy if no bleeding and no severe 
airway stenosis due to laryngopharyngeal edema is confirmed. The endotracheal 
tube is basically extubated immediately after surgery. In cases with suspected 
airway stenosis risk, extubation should be performed under preparation for 
immediate reintubation using a tube exchanger. Patients who have a high risk of 
bleeding after surgery or severe laryngopharyngeal swelling due to long surgery 
or neck dissection should be kept intubated or should undergo tracheostomy 
without hesitation.
Figure 4. 
Step-by-step procedure (Hypopharyngeal cancer, Rt. piriform sinus lesion). a. outside view of TOVS, b. 
observation with normal light, c. observation with NBI, d. observation after iodine staining, e. marking of the 
mucosal incision line, f. resection from the oral side, g. resection of the muscular layer, h. resection of the inner 
border of the thyroid cartilage, i. resection of the caudal end, j. view after resection, k. hemostasis using vessel 
clip, l. view after spraying of fibrin glue.
Pharynx - Diagnosis and Treatment
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Figure 5. 
Inside-out anatomy of the larynx and hypopharynx. a. Landmarks of the larynx and hypopharynx. b. 
Location of the carotid artery after surgical field exposure. a. Artery, n. nerve.
6. Management of lymph node metastasis
For patients with node-positive disease, ND is performed after TOVS on the 
same day. Some patients may undergo ND separately within 1–2 weeks of TOVS.
The veins around the laryngopharynx should be preserved whenever possible to 
reduce postoperative laryngeal edema due to temporal insufficiency of blood flow. 
In N2c cases treated with bilateral NDs, severe edema of the entire laryngopharynx 
can occur. Therefore, careful attention should be paid to postoperative airway 
management and prophylactic tracheostomy should be considered.
Perforation between the wound of the TOVS and the neck can occur during 
ND. In such cases, postoperative infections, particularly around the carotid 
artery or retropharyngeal space, might be a fatal complication. Therefore, 
closure using a muscular flap should be performed and careful and intensive 
postoperative management to prevent subcutaneous emphysema and infections 
are necessary.
7. Anatomical tips for TOVS in hypopharyngeal cancer
The tips of the inside-out anatomy of the larynx and hypopharynx are shown 
in Figure 5a. The superior laryngeal artery and superior laryngeal nerve enter the 
laryngopharynx through the thyrohyoid membrane. The superior laryngeal nerve 
runs along the submucosal layer of the anterior wall of the pyriform sinus. The 
recurrent laryngeal nerve runs in a deep layer between the inferior cornu of the 
thyroid cartilage and the posterior cricoarytenoid muscle. The superficial branch 
of the recurrent laryngeal nerve usually causes anastomosis with the superficial 
laryngeal nerve (Galen’s anastomosis).
9
Transoral Videolaryngoscopic Surgery (TOVS)
DOI: http://dx.doi.org/10.5772/intechopen.97473
The carotid artery is close to the surgical field in some cases of angiectopia. The 
carotid artery is also close to the surgical field in cases of excessive laryngopharyn-
geal suspension to better expose the surgical field. The retractor opens the space 
between the alar of the thyroid cartilage and the prevertebral space, which causes 
the shift of the carotid artery from lateral to medial. As a result, the carotid artery 
becomes adjacent to the area between the posterior wall and the outer wall of the 
piriform sinus behind the alar of the thyroid cartilage (Figure 5b). Therefore, espe-
cially in the case that includes the pharyngeal constrictor muscle layer resection, the 
procedure should be performed with careful caution. Since this cannot be predicted 
by preoperative imaging, it is necessary to estimate the position of the carotid artery 
by careful observation of the arterial pulsation in the endoscopic view and the shift 
of the pulsating site by manual compression from the outside of the neck.
In the case of deeper infiltration in the posterior wall, the resection should also 
be performed with careful caution. When an excision of all layers of the pharyngeal 
constrictor muscle is performed, deeper damage from the buccopharyngeal fascia 
to the alar fascia causes perforation of the danger space in the retropharyngeal space 
(Figure 5a). This damage may cause severe postoperative complications such as 
cervical spondylitis and/or mediastinitis. In particular, post-irradiated cases have 
a high risk of developing complications due to poor wound healing and increased 
susceptibility to infection. Therefore, it is important to preserve the buccopharyn-
geal fascia and alar fascia whenever possible.
To perform better and safer transoral surgery, the surgeon should understand 
and familiarize themselves with the anatomical landmarks inside the laryngophar-
ynx, check the preoperative endoscopic and imaging findings, observe surgical 




Since tracheostomies are not performed in most cases, careful attention should 
be focused on airway management and postoperative bleeding. Laryngopharyngeal 
edema may worsen for a few days after surgery, although problems may not arise at 
the time of extubation. Routine endoscopic observation over time should be per-
formed, and steroid administration should be considered if needed. Postoperative 
bleeding can occur not only immediately but also for more than 2 weeks after 
surgery due to crust removal during the wound healing process. Therefore, careful 
follow-up with a ready for emergency airway management, including tracheostomy, 
is necessary for more than 2 weeks after surgery.
For nutritional management, resurgence of oral intake is considered accord-
ing to the extent of resection and the risk factors of dysphagia (such as age, 
performance status, preoperative swallowing function, and irradiation history). 
However, in cases with small lesions and low risk of dysphagia, oral intake can be 
resumed from the next day. In many cases with extensive, muscular layer resec-
tion and/or arytenoid resection, nasogastric tubal feeding is needed. Swallowing 
examinations such as videofluorography and/or videoendoscopy are usually 
performed within 1 week of surgery. Assessment for oral intake should be judged 
based on these results, and swallowing rehabilitation (direct or indirect training) 
by a speech therapist should be performed, if necessary, with being appropri-
ate re-evaluation. In most cases, a normal diet can be resumed within 1 week to 
1 month of TOVS.
Pharynx - Diagnosis and Treatment
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In cases without any postoperative complications such as airway, bleeding, 
infection, and dysphagia, the patient can be discharged from the hospital. Patients 
with small lesions are usually discharged within 1–2 weeks after TOVS.
8.2 Long-term management
It is important to consider the possibility of pneumonia due to silent aspiration. 
Only a few percent of patients have long-term dysphagia [5, 10]. If long-term oral 
intake is difficult, gastrostomy is considered.
Epithelization of the wound healing occurs 1–2 months after TOVS in most 
cases. However, wound healing is very slow and takes more than 6 months in some 
previously irradiated cases [8]. In such cases, the risk of infection is high. Serious 
complications such as cervical spondylitis and mediastinitis can occur after more 
than 6 months after surgery. Long-term antibiotic administration is required in 
some cases. In addition, it is difficult to discriminate infection/inflammation from 
recurrence; therefore, long-term follow-up with careful observation is necessary.
Wound adhesion and scar formation due to wound healing causes fixation of 
the cricoarytenoid joint in some cases of extensive pyriform sinus resection. In such 
cases, restriction of vocal fold movement and insufficient glottic closure may occur 
several months after TOVS. Although there is no problem with laryngeal function 
immediately after surgery, dysphagia and voice disorder might worsen over a few 
months after TOVS. Intraoperative local steroid injection (triamcinolone acetonide) 
is effective; however, its indications should be limited only to new cases with exten-
sive excision of the pyriform sinus, postcricoid, and/or esophageal inlet lesions, as 
described in Section 5.4 [9].
8.3 Oncological management and additional treatments
The pathological assessment of surgical margins in the resected permanent 
specimen is often difficult due to cauterization. Therefore, the margins are uncer-
tain in some cases. In cases with horizontal margins, careful follow-up enables early 
detection, even in the case of recurrence. However, in cases with deep margins, 
early detection of recurrent lesions may be difficult after wound healing. In such 
cases, a second-look operation after 2–3 months of TOVS or postoperative irradia-
tion should be considered.
According to pathological findings, patients might undergo postoperative radia-
tion therapy (RT) or chemoradiation therapy (CRT). Definite positive margins, 
multiple lymph node metastases, extranodal extension, and perineural invasion are 
indications for RT or CRT.
9. Representative cases
9.1 Case 1: 64-year-old male, hypopharynx cancer, pT3N0M0
The lesion was extended from the left pyriform sinus to the posterior wall and 
anterior surface of the epiglottis (Figure 6).
9.2 Case2: 58 years-old male, hypopharyngeal cancer, rT2N0M0
Chemoradiotherapy for hypopharyngeal cancer (T3N0M0), was performed 
2 years before TOVS. The recurrent lesion was located more than half of the poste-
rior wall to the esophageal inlet (Figure 7).
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Figure 6. 
Case 1. a. Pre-operative endoscopic view, b. observation with Normal light: Lesion was extended from left 
piriform sinus to posterior wall. c. Observation with Normal light: Lesion was extended to the left side of the 
anterior surface of the epiglottis. d. Observation with NBI, e. observation after iodine staining: Left piriform 
sinus to the posterior wall, f. observation after iodine staining: Anterior surface of epiglottis, g. resection from 
the left side of the anterior surface of the epiglottis to the upper side of the piriform sinus. h. Resection of the 
left piriform sinus to the lateral wall, i. removal of resected en block specimen, j. view after resection: Left 
piriform sinus to posterior wall, k. view after resection: Resected anterior surface and left edge of epiglottis, l. 
postoperative endoscopic view (2 months after TOVS).
Figure 7. 
Case 2. a. Pre-operative endoscopic view, b. observation with Normal light, c. observation with NBI, d. 
marking of the mucosal incision line, e. resection from Musclar layer of oral side, f. resection of the whole layer 
of pharyngeal constrictor muscle, g. view after resection: Ara fascia was preserved. h. View after spraying fibrin 
grue, i. postoperative endoscopic view (9 months after TOVS).
Pharynx - Diagnosis and Treatment
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9.3 Case3: 72-year-old male, hypopharynx cancer, rT3N0M0
Chemoradiotherapy for hypopharyngeal cancer (T2NM0) was performed 
10 years before TOVS. The recurrent lesion was located from the right side of 
postcricoid to left side posterior wall, esophageal inlet (Figure 8).
10. Outcomes
10.1 Oncological outcome
A recent report by Tomifuji et al. demonstrated excellent outcomes of TOVS for 
both new and salvage cases [5]. In 83 new hypopharyngeal cancer cases, the 2-year 
overall survival (OS), disease-specific survival (DSS), local control rate (LCR), laryn-
geal preservation rate (LPR), and disease-free survival (DFS) were 90.6%, 97.4%, 
96.3%, 96.9%, and 80.40%, respectively, and the 5-year OS, DSS, LCR, LPR, and 
DFS were 83.2%, 94.3%, 94.7%, 94.6%, and 73.0%, respectively. In 12 salvage cases of 
hypopharyngeal and supraglottic cancer after RT or CRT, the 2-year OS, DSS, LCR, 
LPR, and DFS were 100%, 100%, 75%, 91.7%, and 75%, respectively, and the 5-year 
OS, DSS, LCR, LPR, and DFS were 87.5%, 87.5%, 75%, 82.5%, and 75%, respectively. 
Regarding T classification, advanced T stage showed worse OS and DSS outcomes 
than early stage. Regarding N classification, patients with N3 neck disease showed a 
significantly worse prognosis in terms of OS and DSS.
Among 115 cases of hypopharyngeal and supraglottic cancer, 20.8% of patients 
had a previous history of RT or CRT in the neck, 28.7% of patients were performed 
postoperative RT or CRT. As the result, 50.4% of patients could be spared RT or 
CRT [5].
10.2 Functional outcome
Regarding swallowing functional outcomes, most patients maintain good oral 
food intake. Among 115 patients more than 6 months after TOVS, the functional 
outcome swallowing scale (FOSS) score, which divides the swallowing function 
Figure 8. 
Case 3. a. Observation with normal light, b. observation with NBI, c. marking of the mucosal incision line, 
d. resection right side of postcricoid to esophageal inlet, e. removal of resected en block specimen, f. view after 
resection: More than half of the posterior wall and the esophageal inlet were resected.
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into six stages, was 0 in 65% patients, 1 in 20% patients, 2 in 4.3% patients, 3 in 
7.0% patients, and 4 in 3.5% patients (0–2, stable status; 3, unstable status requir-
ing occasional follow-up of swallowing function; and 4–5, life-threatening status 
requiring tube feeding or surgical intervention). In 3.4% of patients, oral food 
intake could not be achieved within 6 months of surgery and required tube feeding, 
total pharyngolaryngectomy due to severe pharyngeal stenosis, or laryngotracheal 
separation surgery. Another 1.7% of patients had deteriorated swallowing func-
tion after 4.5 years and 7 years of TOVS and underwent laryngotracheal separation 
surgery to prevent aspiration pneumonia. Therefore, 5.2% of patients could not 
maintain oral intake during the long-term follow-up [5]. The risk factors associated 
with postoperative severe dysphagia include patient age (particularly >80 years), 
large resection area, arytenoid and/or pyriform sinus resection, pulmonary dys-
function, and tracheostomy [10].
Postoperative voice impairment was found in 29.1% of hypopharyngeal and 
supraglottic cancer cases 6–12 months after TOVS. Scar contracture after wound 
healing was the mechanism described in Section 8.2. Large resection area including 
the medial and lateral pyriform sinuses was the risk factor [11]. Surgeons should 
inform the patients regarding the risk of postoperative voice impairment during 
pre-operative counseling.
10.3 Complications
In 115 cases of hypopharyngeal and supraglottic cancer, the major complications 
related to TOVS were neck emphysema (7.8%, conservative observation: 100%), 
airway edema (6.9%, steroid treatment: 88%, tracheostomy: 12%), bleeding (2.6%, 
tracheostomy: 67%, reoperation: 33%), partial laryngopharyngeal necrosis due to 
postoperative RT and CRT (1.7%), perforation of the neck (0.86%), and laryngeal 
chondritis (0.86%) [5].
The proportion of patients avoiding endotracheal tube extubation immediately 
after surgery and maintain intubation for 1 day due to long operation time or poor 
oxygenation was 1.7%. Tracheostomy was performed in 9.5% of patients—in 4.3% 
of patients, prophylactic tracheostomy was performed; in 3.4% of patients, emer-
gency tracheostomy was performed; and in 1.7% of patients, preoperative trache-
ostomy was performed due to dyspnea or difficulty of intubation. Tracheostomy 
could not be closed due to persistent laryngeal stenosis and persistent dysphagia in 
3.4% of all patients undergoing TOVS [5].
11. Future directions
11.1 Development of devices
In the early phase of TOVS establishment, a major problem in the surgical 
procedure was the conflict of instruments in the narrow laryngopharyngeal cavity 
due to the straight shape of the endoscope and forceps. In recent years, endoscopes, 
forceps, CO2 lasers, and electrocautery with flexibility have been commercially 
available (Figure 1d).
The currently available endoscopes are designed for two-dimensional imag-
ing. Therefore, TORS, which uses three-dimensional (3D) imaging, is considered 
superior to TOVS. However, the newly developed 3D endoscopes that can be used 
for TOVS will be commercially available soon. TOVS has the advantage of having 
tactile sense; hence, it can be a more suitable surgery for hypopharyngeal lesions 
using a 3D endoscope than TORS.
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In addition, new curved blades for the FK-WO retractor have been developed 
(Figure 3). In a trial conducted in our department, new curved blades enabled 
appropriate exposure of surgical fields in the pyriform sinus apex and esophageal 
inlet in five cases with poor surgical field exposure using conventional blades, and 
surgical procedures could be accomplished in all cases. While using curved blades, 
the surgical maneuver is occasionally difficult with straight devices; however, mal-
leable devices fit well [5].
With the continuous development of devices and by combining devices such as 
3D endoscopes, malleable devices, and new curved blades, TOVS will be an easier 
procedure with a broad indication of the entire laryngopharynx and will be a more 
accomplished surgery with better oncological outcomes and safety.
11.2 Management of lymph node metastasis
Cervical lymph node metastasis is one of the most important prognostic fac-
tors in head and neck squamous cell carcinoma. Although many cases of transoral 
surgery are in the early stage with a clinically node-negative (cN0) status, the rate 
of positive lymph node metastasis in patients with cN0 laryngopharyngeal cancer is 
approximate 20–30%. Therefore, it is debatable whether neck dissection should be 
performed immediately in cN0 cases.
Tomifuji et al. reported the relationship between the histological parameters of 
resected primary lesions of TOVS and lymph node metastasis in supraglottic and 
hypopharyngeal cancers. Tumor depth and venous invasion were the most useful 
parameters for predicting lymph node metastases. They recommended that elective 
ND should be considered when the tumor depth is >1 mm and/or there is a pres-
ence of venous invasion. Moreover, careful observation when the tumor depth is 
between 0.5 and 1 mm, and, regular clinical follow-up when <0.5 mm, are recom-
mended, respectively [12].
Another promising strategy for the management of lymph node metastasis is 
sentinel node navigation surgery (SNNS). It enables a personalized evaluation 
for neck dissection in cN0 cases individually, thereby eliminating unnecessary 
ND. Araki et al. reported a multicenter feasibility study of the combination of 
transoral surgery with SNNS for laryngopharyngeal cancer using an intraop-
erative injection of indocyanine green. In 22 patients with cN0 hypopharynx, 
oropharynx, or supraglottic cancer, the accuracy, sensitivity, and specificity of 
the combination strategy were 95.5%, 75%, and 100%, respectively. The 5-year 
DSS rate was 100%, and OS was 72.3% [13]. This combination strategy holds 
promise as a feasible tool for personalized and minimally invasive treatment 
options for both primary lesions and lymph node metastasis with favorable 
oncological outcomes.
11.3 Conversion surgery with neoadjuvant chemotherapy (NAC)
While the major indications for TOVS are early-stage up to T2, TOVS can be 
performed in selected cases with advanced lesions when NAC is effective for 
shrinking the lesions. Tomifuji et al. reported good results of conversion  
surgery with NAC. In the cases of T3 and T4 hypopharyngeal cancer treated 
by NAC (cisplatin +5FU or docetaxel + cisplatin +5FU) followed by TOVS, the 
5-year OS, DSS, LCR, LPR, and DFS were 75.0%, 82.5%, 91.7%, 100%, and 
66.7%, respectively [5].
Although this strategy of conversion surgery seems to be effective, it also has 
an issue. When lesions shrink by NAC, the remaining lesion may be a single mass 
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in some cases or multiple scattered lesions in other cases. When the resection area 
is limited to shrunk lesions, some of the scattered lesions outside the resection area 
might be missed despite the negative resection margin. The resection areas after 
NAC should be determined according to the initial lesions, and it is technically 
difficult to completely resect the entire area of the original advanced lesions. Hence, 
the indication of TOVS as a conversion surgery for advanced lesions should be lim-
ited to highly selected cases, and research on an appropriate and effective strategy 
for conversion surgery with NAC is necessary for the future.
11.4 Other than laryngopharyngeal cancer surgery
TOVS can be applied to any other surgery in addition to that for primary laryn-
gopharyngeal cancer. Parapharyngeal and retropharyngeal metastatic lesions can 
be treated by TOVS in combination with a navigation system [14]. Less invasiveness 
surgery is needed for benign diseases in the laryngopharyngeal region compared 
to that for malignant diseases. The technique of TOVS has great benefits as a 
minimally invasive surgery for benign diseases including cysts, papilloma, benign 
Figure 9. 
56-year-old male, recurrent laryngeal pleomorphic adenoma. The orginal lesion was resected 1 year ago at 
another hospital. The recurrent lesion was located right arytenoid to aryepiglottic fold. a. Pre-operative 
endoscopic view, b. pre-operative view of surgical field, c. resection from inter arytenoid to right arytenoid, 
d. resection of right aryepiglottic fold, e. view after resection: Whole right arytenoid to aryepiglottic fold was 
resected and fibring grue is sprayed. f. Post-operative endoscopic view (9 months after TOVS).
Figure 10. 
19-year-old female, Neurofibromatosis type2. The lesion was located left arytenoid. a. Preoperative view of 
surgical field, b. resection of the lesion.
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Figure 11. 
30-year-old female, pyriform sinus fistula. a. Pre-operative view of surgical field, b. resection of the duct as far 
as possible, c. suture closure of mucosa, e. view after mucosal closure.
tumors (Figures 9, 10), pyriform sinus fistula [15] (Figure 11), foreign bodies, 
injection laryngoplasty for unilateral vocal cord palsy, cricopharyngeal myotomy 
for dysphagia, laryngopharyngeal dilatation surgery for stenosis and so on.
12. Conclusions
TOVS is a minimally invasive organ preservation surgery for laryngopharyngeal 
cancer with good oncological and functional outcomes. The procedure of this 
surgery has some advantage in maneuver and less invasiveness when compared to 
TLM and TORS, especially for hypopharyngeal cancer. It is expected that transoral 
surgery including TOVS will become increasingly popular as one of the standard 
treatments with the development of devices and establishing the evidence by 
accumulating cases.
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